Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pancreatitis

  Free Subscription


Articles published in Surgery

Retrieve available abstracts of 95 articles:
HTML format
Text format



Single Articles


    March 2018
  1. LIU L, Xu HX, He M, Wang W, et al
    A novel scoring system predicts postsurgical survival and adjuvant chemotherapeutic benefits in patients with pancreatic adenocarcinoma: Implications for AJCC-TNM staging.
    Surgery. 2018 Mar 13. pii: S0039-6060(18)30033.
    PubMed     Text format     Abstract available


  2. SHANBHAG ST, Choong B, Petrov M, Delahunt B, et al
    Acute pancreatitis conditioned mesenteric lymph causes cardiac dysfunction in rats independent of hypotension.
    Surgery. 2018 Mar 5. pii: S0039-6060(17)30885-1. doi: 10.1016/j.surg.2017.
    PubMed     Text format     Abstract available


  3. KANTOR O, Pitt HA, Talamonti MS, Roggin KK, et al
    Minimally invasive pancreatoduodenectomy: is the incidence of clinically relevant postoperative pancreatic fistula comparable to that after open pancreatoduodenectomy?
    Surgery. 2018;163:587-593.
    PubMed     Text format     Abstract available


    February 2018
  4. SHEN Y, Chaurasiya S, Bai X, Liang T, et al
    Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society.
    Surgery. 2018 Feb 7. pii: S0039-6060(17)30932-7. doi: 10.1016/j.surg.2017.
    PubMed     Text format    


  5. POMMIER RF
    Editorial: peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms.
    Surgery. 2018 Feb 5. pii: S0039-6060(17)30926-1. doi: 10.1016/j.surg.2017.
    PubMed     Text format    


    January 2018
  6. BLAIR AB, Rosati LM, Rezaee N, Gemenetzis G, et al
    Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy.
    Surgery. 2018 Jan 25. pii: S0039-6060(17)30874.
    PubMed     Text format     Abstract available


  7. LIANG D, Shi S, Liang C, Meng Q, et al
    Mismatch repair status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for pancreatic cancer.
    Surgery. 2018 Jan 15. pii: S0039-6060(17)30878.
    PubMed     Text format     Abstract available


  8. DREIJERINK KMA
    Letter to the editors regarding: genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: a 23-year experience at a single institution.
    Surgery. 2018 Jan 12. pii: S0039-6060(17)30884.
    PubMed     Text format    


  9. BATCHU RB, Gruzdyn OV, Mahmud EM, Chukr F, et al
    Inhibition of Interleukin-10 in the tumor microenvironment can restore mesothelin chimeric antigen receptor T cell activity in pancreatic cancer in vitro.
    Surgery. 2018 Jan 11. pii: S0039-6060(17)30794.
    PubMed     Text format     Abstract available


  10. SUSS NR, Talamonti MS, Bryan DS, Wang CH, et al
    Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer?
    Surgery. 2018 Jan 11. pii: S0039-6060(17)30654.
    PubMed     Text format     Abstract available


    December 2017
  11. PARTELLI S, Bertani E, Bartolomei M, Perali C, et al
    Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms.
    Surgery. 2017 Dec 25. pii: S0039-6060(17)30827.
    PubMed     Text format     Abstract available


  12. KOWALSKY SJ, Zenati MS, Dhir M, Schaefer EG, et al
    Postoperative narcotic use is associated with development of clinically relevant pancreatic fistulas after distal pancreatectomy.
    Surgery. 2017 Dec 18. pii: S0039-6060(17)30780.
    PubMed     Text format     Abstract available


  13. SWORDS DS, Zhang C, Presson AP, Firpo MA, et al
    Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery.
    Surgery. 2017 Dec 13. pii: S0039-6060(17)30792.
    PubMed     Text format     Abstract available


  14. CARR RA, Yip-Schneider MT, Simpson RE, Dolejs S, et al
    Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts.
    Surgery. 2017 Dec 11. pii: S0039-6060(17)30704.
    PubMed     Text format     Abstract available


  15. DATE K, Ohtsuka T, Nakamura S, Mochidome N, et al
    Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma.
    Surgery. 2017 Dec 5. pii: S0039-6060(17)30687-6. doi: 10.1016/j.surg.2017.
    PubMed     Text format     Abstract available


    November 2017
  16. MOORE MD, Finnerty B, Gray KD, Hoda R, et al
    Decreased UCHL1 expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors.
    Surgery. 2017 Nov 14. pii: S0039-6060(17)30598.
    PubMed     Text format     Abstract available


  17. CHRISTAKIS I, Qiu W, Hyde SM, Cote GJ, et al
    Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution.
    Surgery. 2017 Nov 6. pii: S0039-6060(17)30606-2. doi: 10.1016/j.surg.2017.
    PubMed     Text format     Abstract available


  18. MORGAN RE, Pommier SJ, Pommier RF
    Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors.
    Surgery. 2017 Nov 2. pii: S0039-6060(17)30627-X. doi: 10.1016/j.surg.2017.
    PubMed     Text format     Abstract available


    August 2017
  19. HERNANDEZ JM, Brown ZJ, D'Angelica MI
    A palpable pancreatic duct.
    Surgery. 2017 Aug 28. pii: S0039-6060(17)30488.
    PubMed     Text format    


  20. VAN RIJSSEN LB, Besselink MG, Buchler MW, Busch OR, et al
    Reply to a letter to the editor regarding the International Study Group on Pancreatic Surgery definition and classification of chyle leak after pancreatic operation.
    Surgery. 2017 Aug 11. pii: S0039-6060(17)30438.
    PubMed     Text format    


    July 2017
  21. SAHAKYAN MA, Kim SC, Kleive D, Kazaryan AM, et al
    Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: Long-term oncologic outcomes after standard resection.
    Surgery. 2017 Jul 27. pii: S0039-6060(17)30401.
    PubMed     Text format     Abstract available


  22. DE PASTENA M, Paiella S, Marchegiani G, Malleo G, et al
    Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center.
    Surgery. 2017 Jul 1. pii: S0039-6060(17)30382-3. doi: 10.1016/j.surg.2017.
    PubMed     Text format     Abstract available


    June 2017
  23. TRAN CAO HS, Zhang Q, Sada YH, Silberfein EJ, et al
    Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
    Surgery. 2017 Jun 27. pii: S0039-6060(17)30321.
    PubMed     Text format     Abstract available


  24. YAMADA S, Fujii T, Takami H, Hayashi M, et al
    Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society.
    Surgery. 2017 Jun 24. pii: S0039-6060(17)30330.
    PubMed     Text format     Abstract available


  25. DEBS T, Petrucciani N, Kassir R, Ouvrier D, et al
    Chylous leak after pancreatic resection: A grading system was needed.
    Surgery. 2017 Jun 8. pii: S0039-6060(17)30310-0. doi: 10.1016/j.surg.2017.
    PubMed     Text format    


    May 2017
  26. ADDEO P, Velten M, Averous G, Faitot F, et al
    Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.
    Surgery. 2017 May 30. pii: S0039-6060(17)30164.
    PubMed     Text format     Abstract available


  27. KASUMOVA GG, Eskander MF, de Geus SWL, Neto MM, et al
    Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy.
    Surgery. 2017 May 6. pii: S0039-6060(17)30165-4. doi: 10.1016/j.surg.2017.
    PubMed     Text format     Abstract available


    March 2017
  28. JUN E, Kim SC, Song KB, Hwang DW, et al
    Diagnostic value of chromogranin A in pancreatic neuroendocrine tumors depends on tumor size: A prospective observational study from a single institute.
    Surgery. 2017 Mar 2. pii: S0039-6060(17)30080-6. doi: 10.1016/j.surg.2017.
    PubMed     Text format     Abstract available


  29. DE GEUS SW, Eskander MF, Bliss LA, Kasumova GG, et al
    Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
    Surgery. 2017;161:592-601.
    PubMed     Text format     Abstract available


    February 2017
  30. BIRNBAUM DJ, Gaujoux S, Berbis J, Dokmak S, et al
    Surgery for pancreatic neoplasms: How accurate are our surgical indications?
    Surgery. 2017 Feb 22. pii: S0039-6060(17)30076.
    PubMed     Text format     Abstract available


  31. KIM HW, Lee JC, Paik KH, Kang J, et al
    Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.
    Surgery. 2017 Feb 22. pii: S0039-6060(17)30017.
    PubMed     Text format     Abstract available


  32. SWORDS DS, Firpo MA, Johnson KM, Boucher KM, et al
    Implications of inaccurate clinical nodal staging in pancreatic adenocarcinoma.
    Surgery. 2017 Feb 18. pii: S0039-6060(17)30006.
    PubMed     Text format     Abstract available


  33. SCHMIDT A, Sinnett-Smith J, Young S, Chang HH, et al
    Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
    Surgery. 2017 Feb 17. pii: S0039-6060(17)30016.
    PubMed     Text format     Abstract available


    January 2017
  34. KANEKO H, Kokuryo T, Yokoyama Y, Yamaguchi J, et al
    Novel therapy for pancreatic fistula using adipose-derived stem cell sheets treated with mannose.
    Surgery. 2017 Jan 28. pii: S0039-6060(16)30881.
    PubMed     Text format     Abstract available


  35. TEO R, Goh BK, Tai DW, Allen JC, et al
    Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A single-institution experience with 176 patients.
    Surgery. 2017 Jan 19. pii: S0039-6060(16)30852.
    PubMed     Text format     Abstract available


  36. SHIRAI Y, Uwagawa T, Shiba H, Shimada Y, et al
    Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-kappaB activation.
    Surgery. 2017 Jan 13. pii: S0039-6060(16)30859.
    PubMed     Text format     Abstract available


    December 2016
  37. SCHEUFELE F, Schorn S, Demir IE, Sargut M, et al
    Preoperative biliary stenting versus operation first in jaundiced patients due to malignant lesions in the pancreatic head: A meta-analysis of current literature.
    Surgery. 2016 Dec 30. pii: S0039-6060(16)30732.
    PubMed     Text format     Abstract available


  38. BASSI C, Marchegiani G, Dervenis C, Sarr M, et al
    The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After.
    Surgery. 2016 Dec 28. pii: S0039-6060(16)30757.
    PubMed     Text format     Abstract available


  39. SHRIKHANDE SV, Sivasanker M, Vollmer CM, Friess H, et al
    Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS).
    Surgery. 2016 Dec 24. pii: S0039-6060(16)30764.
    PubMed     Text format     Abstract available


  40. ABE T, Ohuchida K, Endo S, Ookubo F, et al
    Clinical importance of intraoperative peritoneal cytology in patients with pancreatic cancer.
    Surgery. 2016 Dec 7. pii: S0039-6060(16)30733-4. doi: 10.1016/j.surg.2016.
    PubMed     Text format     Abstract available


  41. DELITTO D, Judge SM, George TJ Jr, Sarosi GA, et al
    A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer.
    Surgery. 2016 Dec 5. pii: S0039-6060(16)30635-3. doi: 10.1016/j.surg.2016.
    PubMed     Text format     Abstract available


    November 2016
  42. ESKANDER MF, de Geus SW, Kasumova GG, Ng SC, et al
    Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer.
    Surgery. 2016 Nov 16. pii: S0039-6060(16)30618.
    PubMed     Text format     Abstract available


  43. HACKERT T, Klaiber U, Hinz U, Kehayova T, et al
    Sphincter of Oddi botulinum toxin injection to prevent pancreatic fistula after distal pancreatectomy.
    Surgery. 2016 Nov 16. pii: S0039-6060(16)30505.
    PubMed     Text format     Abstract available


  44. XU HX, Liu L, Xiang JF, Wang WQ, et al
    Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
    Surgery. 2016 Nov 9. pii: S0039-6060(16)30422-6. doi: 10.1016/j.surg.2016.
    PubMed     Text format     Abstract available


  45. NAGLE RT, Leiby BE, Lavu H, Rosato EL, et al
    Pneumonia is associated with a high risk of mortality after pancreaticoduodenectomy.
    Surgery. 2016 Nov 8. pii: S0039-6060(16)30614-6. doi: 10.1016/j.surg.2016.
    PubMed     Text format     Abstract available


    October 2016
  46. ERTEL AE, Wima K, Hoehn RS, Chang AL, et al
    Variability in postoperative resource utilization after pancreaticoduodenectomy: Who is responsible.
    Surgery. 2016 Oct 3. pii: S0039-6060(16)30465-2. doi: 10.1016/j.surg.2016.
    PubMed     Text format     Abstract available


    September 2016
  47. BESSELINK MG, van Rijssen LB, Bassi C, Dervenis C, et al
    Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery.
    Surgery. 2016 Sep 28. pii: S0039-6060(16)30417.
    PubMed     Text format     Abstract available


  48. KANTOR O, Talamonti MS, Lutfi W, Wang CH, et al
    External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
    Surgery. 2016 Sep 7. pii: S0039-6060(16)30410-X. doi: 10.1016/j.surg.2016.
    PubMed     Text format     Abstract available


    August 2016
  49. AUGUSTIN T, Burstein MD, Schneider EB, Morris-Stiff G, et al
    Frailty predicts risk of life-threatening complications and mortality after pancreatic resections.
    Surgery. 2016 Aug 18. pii: S0039-6060(16)30342.
    PubMed     Text format     Abstract available


  50. GLEESON EM, Shaikh MF, Shewokis PA, Clarke JR, et al
    WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database.
    Surgery. 2016 Aug 17. pii: S0039-6060(16)30325.
    PubMed     Text format     Abstract available


  51. SHUBERT CR, Bergquist JR, Groeschl RT, Habermann EB, et al
    Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Surgery. 2016 Aug 10. pii: S0039-6060(16)30237.
    PubMed     Text format     Abstract available


    July 2016
  52. SHERMAN JL, Shi EW, Ranasinghe NE, Sivasankaran MT, et al
    Corrigendum to 'Validation and improvement of a proposed scoring system to detect retained common bile duct stones in gallstone pancreatitis': Surgery 2015;157:1073-9.
    Surgery. 2016 Jul 26. pii: S0039-6060(16)30217.
    PubMed     Text format    


  53. GLAZER ES, Rashid OM, Pimiento JM, Hodul PJ, et al
    Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Surgery. 2016 Jul 20. pii: S0039-6060(16)30210.
    PubMed     Text format     Abstract available


  54. DHAR VK, Levinsky NC, Xia BT, Abbott DE, et al
    The natural history of chronic pancreatitis after operative intervention: The need for revisional operation.
    Surgery. 2016 Jul 20. pii: S0039-6060(16)30208.
    PubMed     Text format     Abstract available


  55. LUTFI W, Talamonti MS, Kantor O, Wang CH, et al
    Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
    Surgery. 2016 Jul 12. pii: S0039-6060(16)30204.
    PubMed     Text format     Abstract available


    June 2016
  56. BERGQUIST JR, Thiels CA, Storlie CB, Nagorney DM, et al
    How matching may impact interpretation: Comments on "A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB)".
    Surgery. 2016 Jun 27. pii: S0039-6060(16)30149.
    PubMed     Text format    


  57. MERDRIGNAC A, Bergeat D, Rayar M, Harnoy Y, et al
    Frey procedure combined with biliary diversion in chronic pancreatitis.
    Surgery. 2016 Jun 16. pii: S0039-6060(16)30134.
    PubMed     Text format     Abstract available


    May 2016
  58. OHGI K, Sugiura T, Yamamoto Y, Okamura Y, et al
    Bacterobilia may trigger the development and severity of pancreatic fistula after pancreatoduodenectomy.
    Surgery. 2016 May 24. pii: S0039-6060(16)30045.
    PubMed     Text format     Abstract available


    April 2016
  59. KLAIBER U, Alldinger I, Probst P, Bruckner T, et al
    Duodenum-preserving pancreatic head resection: 10-year follow-up of a randomized controlled trial comparing the Beger procedure with the Berne modification.
    Surgery. 2016 Apr 19. pii: S0039-6060(16)00150.
    PubMed     Text format     Abstract available


  60. PANICCIA A, Hosokawa PW, Schulick RD, Henderson W, et al
    A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB).
    Surgery. 2016 Apr 14. pii: S0039-6060(16)00147.
    PubMed     Text format     Abstract available


  61. KAWAI M, Murakami Y, Motoi F, Sho M, et al
    Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observational study.
    Surgery. 2016 Apr 12. pii: S0039-6060(16)00154.
    PubMed     Text format     Abstract available


  62. TACHEZY M, Gebauer F, Janot M, Uhl W, et al
    Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
    Surgery. 2016 Apr 2. pii: S0039-6060(16)00093-3. doi: 10.1016/j.surg.2016.
    PubMed     Text format     Abstract available


    March 2016
  63. DIVINO CM, Sherman J
    Reply to: Accuracy of scoring systems for suspected choledocholithiasis.
    Surgery. 2016;159:986.
    PubMed     Text format    


    February 2016
  64. STARK AP, Sacks GD, Rochefort MM, Donahue TR, et al
    Long-term survival in patients with pancreatic ductal adenocarcinoma.
    Surgery. 2016 Feb 1. pii: S0039-6060(16)00004-0. doi: 10.1016/j.surg.2015.
    PubMed     Text format     Abstract available


    December 2015
  65. OKADA KI, Kawai M, Hirono S, Fujii T, et al
    Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial.
    Surgery. 2015 Dec 31. pii: S0039-6060(15)00966.
    PubMed     Text format     Abstract available


  66. CRIPPA S, Pergolini I, Rubini C, Castelli P, et al
    Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.
    Surgery. 2015 Dec 15. pii: S0039-6060(15)00938.
    PubMed     Text format     Abstract available


  67. MCMILLAN MT, Christein JD, Callery MP, Behrman SW, et al
    Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy.
    Surgery. 2015 Dec 6. pii: S0039-6060(15)00905-8. doi: 10.1016/j.surg.2015.
    PubMed     Text format     Abstract available


    November 2015
  68. REGENET N, Carrere N, Boulanger G, de Calan L, et al
    Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter study.
    Surgery. 2015 Nov 14. pii: S0039-6060(15)00830.
    PubMed     Text format     Abstract available


  69. ROSENBERG AM, Friedmann P, Del Rivero J, Libutti SK, et al
    Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
    Surgery. 2015 Nov 4. pii: S0039-6060(15)00840-5. doi: 10.1016/j.surg.2015.
    PubMed     Text format     Abstract available


    October 2015
  70. CHABOT J
    Pancreatic neuroendocrine tumors: Primum non nocere.
    Surgery. 2015 Oct 31. pii: S0039-6060(15)00726.
    PubMed     Text format    


  71. CHRISTIANS KK, Heimler JW, George B, Ritch PS, et al
    Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.
    Surgery. 2015 Oct 23. pii: S0039-6060(15)00812.
    PubMed     Text format     Abstract available


  72. HACKERT T, Hinz U, Pausch T, Fesenbeck I, et al
    Postoperative pancreatic fistula: We need to redefine grades B and C.
    Surgery. 2015 Oct 22. pii: S0039-6060(15)00802.
    PubMed     Text format     Abstract available


  73. OKANO K, Murakami Y, Nakagawa N, Uemura K, et al
    Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy.
    Surgery. 2015 Oct 22. pii: S0039-6060(15)00808.
    PubMed     Text format     Abstract available


  74. KEUTGEN XM, Nilubol N, Glanville J, Sadowski SM, et al
    Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors.
    Surgery. 2015 Oct 6. pii: S0039-6060(15)00702-3. doi: 10.1016/j.surg.2015.
    PubMed     Text format     Abstract available


  75. TARNASKY P, Kedia P
    RE: Validation and improvement of a proposed scoring system to detect retained common bile duct stones in gallstone pancreatitis.
    Surgery. 2015 Oct 6. pii: S0039-6060(15)00659-5. doi: 10.1016/j.surg.2015.
    PubMed     Text format    


    September 2015
  76. EJAZ A, Frank SM, Spolverato G, Mavros M, et al
    Variation in the use of type and crossmatch blood ordering among patients undergoing hepatic and pancreatic resections.
    Surgery. 2015 Sep 15. pii: S0039-6060(15)00620.
    PubMed     Text format     Abstract available


  77. GONZALEZ-GONZALEZ JA, Monreal-Robles R
    Accuracy of scoring systems for suspected choledocholithiasis.
    Surgery. 2015 Sep 10. pii: S0039-6060(15)00630.
    PubMed     Text format    


    August 2015
  78. STARK AP, Chang HH, Jung X, Moro A, et al
    E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
    Surgery. 2015 Aug 18. pii: S0039-6060(15)00603.
    PubMed     Text format     Abstract available


  79. STAHL CC, Moulton J, Vu D, Ristagno R, et al
    Routine use of U-tube drainage for necrotizing pancreatitis: A step toward less morbidity and resource utilization.
    Surgery. 2015 Aug 10. pii: S0039-6060(15)00545.
    PubMed     Text format     Abstract available


  80. HIRONO S, Kawai M, Okada KI, Miyazawa M, et al
    Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
    Surgery. 2015 Aug 4. pii: S0039-6060(15)00537-1. doi: 10.1016/j.surg.2015.
    PubMed     Text format     Abstract available


  81. MIURA JT, Krepline AN, George B, Ritch PS, et al
    Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer.
    Surgery. 2015 Aug 1. pii: S0039-6060(15)00502-4. doi: 10.1016/j.surg.2015.
    PubMed     Text format     Abstract available


    July 2015
  82. WATERS JA, Matos J, Yip-Schneider M, Aguilar-Saavedra JR, et al
    Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Surgery. 2015 Jul 21. pii: S0039-6060(15)00447.
    PubMed     Text format     Abstract available


  83. BATCHU RB, Gruzdyn OV, Qazi AM, Kaur J, et al
    Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
    Surgery. 2015 Jul 15. pii: S0039-6060(15)00457.
    PubMed     Text format     Abstract available


  84. WILSON GC, Sutton JM, Smith MT, Schmulewitz N, et al
    Completion pancreatectomy and islet cell autotransplantation as salvage therapy for patients failing previous operative interventions for chronic pancreatitis.
    Surgery. 2015 Jul 11. pii: S0039-6060(15)00453.
    PubMed     Text format     Abstract available


  85. HARTWIG W, Gouma DJ, Charnley RM, Buchler MW, et al
    Reply to "Resection of the mesopancreas in pancreatic head adenocarcinoma: Is it outside of the International Study Group on Pancreatic Surgery definition and consensus statement for standard and extended pancreatectomy?".
    Surgery. 2015;158:311-2.
    PubMed     Text format    


    June 2015
  86. HE W, Zhao H, Chan W, Lopez D, et al
    Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
    Surgery. 2015 Jun 29. pii: S0039-6060(15)00360.
    PubMed     Text format     Abstract available


  87. MORALES-OYARVIDE V, Mino-Kenudson M, Ferrone CR, Gonzalez-Gonzalez LA, et al
    Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype.
    Surgery. 2015 Jun 13. pii: S0039-6060(15)00358.
    PubMed     Text format     Abstract available


  88. SALLINEN V, Haglund C, Seppanen H
    Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Surgery. 2015 Jun 9. pii: S0039-6060(15)00365-7. doi: 10.1016/j.surg.2015.
    PubMed     Text format     Abstract available


    May 2015
  89. XU J, Zhang B, Shi S, Qin Y, et al
    Papillary-like main pancreatic duct invaginated pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial.
    Surgery. 2015 May 30. pii: S0039-6060(15)00344.
    PubMed     Text format     Abstract available


  90. SHIRAI Y, Shiba H, Sakamoto T, Horiuchi T, et al
    Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection.
    Surgery. 2015 May 29. pii: S0039-6060(15)00257.
    PubMed     Text format     Abstract available


  91. LANGAN RC, Zheng C, Harris K, Verstraete R, et al
    Hospital-level resource use by the oldest-old for pancreaticoduodenectomy at high-volume hospitals.
    Surgery. 2015 May 23. pii: S0039-6060(15)00249.
    PubMed     Text format     Abstract available


  92. EJAZ A, Spolverato G, Kim Y, Wolfgang CL, et al
    The impact of resident involvement on surgical outcomes among patients undergoing hepatic and pancreatic resections.
    Surgery. 2015 May 20. pii: S0039-6060(15)00236.
    PubMed     Text format     Abstract available


  93. LIU Q, Sheng W, Dong M, Dong X, et al
    Gli1 promotes transforming growth factor-beta1- and epidermal growth factor-induced epithelial to mesenchymal transition in pancreatic cancer cells.
    Surgery. 2015 May 12. pii: S0039-6060(15)00208.
    PubMed     Text format     Abstract available


  94. FAITOT F, Gaujoux S, Barbier L, Novaes M, et al
    Reappraisal of pancreatic enucleations: A single-center experience of 126 procedures.
    Surgery. 2015 May 5. pii: S0039-6060(15)00216-0. doi: 10.1016/j.surg.2015.
    PubMed     Text format     Abstract available


    February 2015
  95. PARDIWALA KH, Maker AV
    Operative management of portal annular pancreas during pancreaticoduodenectomy.
    Surgery. 2015 Feb 25. pii: S0039-6060(14)00613.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: